Theranexus Société Anonyme reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 1.25 million compared to EUR 0.025 million a year ago. Net loss was EUR 6.57 million compared to EUR 8.15 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.135 EUR | +1.34% | +8.10% | +1.34% |
Apr. 19 | Theranexus: share price rises following promising trial results | CF |
Mar. 11 | Theranexus: CEO takes over as Chairman of the Board | CF |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.34% | 9.4M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ALTHX Stock
- News Theranexus
- Theranexus Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022